Image Exchange Services
ID: 24-000058Type: Presolicitation
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFNATIONAL INSTITUTES OF HEALTHNATIONAL INSTITUTES OF HEALTH - CCBETHESDA, MD, 20892, USA

PSC

IT AND TELECOM - PLATFORM PRODUCTS: DATABASE, MAINFRAME, MIDDLEWARE (HW, PERPETUAL LICENSE SOFTWARE) (7H20)

Original Source

https://sam.gov/opp/a05a82db7c34475bb09bfaf3b86609e0/view
Timeline
    Description

    Presolicitation Notice: HEALTH AND HUMAN SERVICES, DEPARTMENT OF - NATIONAL INSTITUTES OF HEALTH is planning to procure Image Exchange Services. These services will allow uploads and sharing of images to and from patients and their provider/provider networks into the Clinical Center in support of research protocols. The services will include cloud-based storage and access provision for exams generated within the Clinical Center, support/training for NIH research personnel, support for patients, and support for all user types within the NIH environment. The procurement will be awarded to CARAHSOFT TECHNOLOGY CORP on a sole source basis.

    Point(s) of Contact
    Christopher Lauver
    (240) 543-2479
    christopher.lauver@nih.gov
    Files
    No associated files provided.
    Lifecycle
    Title
    Type
    Image Exchange Services
    Currently viewing
    Presolicitation
    Similar Opportunities
    Piflufolastat F-18 injection drugs (Pylarify) from Sofie Co. (Notice of Intent to sole source)
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), intends to negotiate a sole-source contract with Sofie Co. for the procurement of Piflufolastat F-18 injection drugs (Pylarify) essential for clinical nuclear medicine procedures at the NIH Clinical Center. This acquisition aims to secure compounded, patient-ready doses of the radiopharmaceutical, which is critical for diagnosing and treating diseases in accordance with patient care protocols. The drugs are FDA-approved and must be compounded and delivered on a time-sensitive basis due to their rapid radiation decay, making Sofie Co. the only authorized provider capable of meeting these specialized requirements. Interested parties may submit capability statements by September 18, 2024, to Lu Chang at lu-chang.lu@nih.gov, as this is not a request for proposals.
    Maintenance Support Agreement-eFlow
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services (HHS) intends to negotiate a sole source contract with NMS Imaging Inc. for maintenance and support of the Electronic Workflow (eFlow) system. This procurement is necessary as NMS Imaging is the sole provider capable of delivering the required maintenance services, having developed and customized the eFlow system. The maintenance and support are critical for the continued functionality and efficiency of the eFlow system, which plays a vital role in HHS operations. Interested parties that believe they can provide the required services must submit a capabilities statement by September 20, 2024, at 12:00 PM Eastern Time to Bryan Daines at bryan.daines@psc.hhs.gov.
    Organizational Change Management, Strategic Planning & Cultural Enhancement - Purchase Order Modification
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is planning to award a Firm-Fixed Price purchase order modification to Schuler Solutions for Organizational Change Management, Strategic Planning, and Cultural Enhancement services. The objective of this procurement is to continue addressing critical areas such as trust, conflict, accountability, and commitment within the NIH's National Eye Institute (NEI) through facilitated retreats, self-assessment sessions, and team discussions, extending into FY2025. This initiative is vital for fostering a safe environment for staff communication and developing administrative best practices. Interested parties that believe they can meet the requirements are encouraged to submit a capability statement by September 20, 2024, to Zetherine Gore at zetherine.gore@nih.gov, referencing notice ID SS-NIH-7070914.
    Request for Information: Computer Aided Facility Management (CAFM) Software System
    Active
    Health And Human Services, Department Of
    The National Institutes of Health, specifically the National Cancer Institute (NCI), is seeking information regarding Computer-Aided Facility Management (CAFM) and Integrated Workplace Management Systems (IWMS) to support its operational needs. The NCI currently utilizes Planon software and is interested in identifying qualified vendors, particularly small businesses, that can provide either authorized reselling of Planon products or alternative commercially-available systems. This initiative is crucial for maintaining efficient facility operations across NCI's extensive real estate portfolio, which includes approximately 125 buildings and 8,500 users. Interested parties should submit their responses by email to Contract Specialist Renee Jones-Chuang at renee.jones-chuang@nih.gov, referencing notice number 75N91024Q00115, as there is no solicitation available at this time and no contract is anticipated to be awarded in Fiscal Year 2024.
    Intent to Sole Source RS Means Software
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), intends to negotiate a sole source contract with The Gordian Group, Inc. for the licensing of RS Means Software. This software is essential for enhancing the accuracy and efficiency of the NIH's construction cost estimation processes, providing reliable and up-to-date cost data critical for project planning and budgeting. The acquisition of RS Means is vital for ensuring precise estimates that reflect current market trends, thereby reducing the risk of cost overruns and improving overall project management. Interested parties that believe they can meet these requirements must respond within five days of the notice, providing necessary company information, as the contract is set to be awarded as a firm-fixed-price purchase order for a one-year period, from September 23, 2024, to September 22, 2025. For further inquiries, contact Amanda Tilton at amanda.tilton@nih.gov or call 301-594-5711.
    Preventative Maintenance Agreement
    Active
    Health And Human Services, Department Of
    Solicitation Notice: HEALTH AND HUMAN SERVICES, DEPARTMENT OF - NATIONAL INSTITUTES OF HEALTH is seeking a Preventative Maintenance Agreement for integration systems used in the current Operating Rooms to the Education Room in Bethesda, Maryland, United States. The purpose of this agreement is to support the existing systems and prevent delay in case the integration system goes down. The agreement requires remote monitoring capabilities, collaboration among NIH and other research institutes, and web-based and teleconference consultation and collaboration. The contract duration includes a base year and two option years. This acquisition is being conducted using policies unique to the Federal Acquisition Regulation (FAR) Part 13. Interested parties may respond to this notice, and the Government will determine whether to compete the requirement based on the responses received.
    NIH Transition to the Department of Treasury’s Invoice Processing Platform (IPP)
    Active
    Health And Human Services, Department Of
    Special Notice: HEALTH AND HUMAN SERVICES, DEPARTMENT OF is transitioning to the Department of Treasury's Invoice Processing Platform (IPP) The Department of Health and Human Services (HHS) is proposing an amendment to the HHS Acquisition Regulation (HHAR) and transitioning to the Department of Treasury's Invoice Processing Platform (IPP). This transition will begin in March 2022 for the National Institutes of Health (NIH)/Office of Financial Management (OFM). The transition will involve a phased approach, with existing awards being modified to incorporate the HHSAR IPP electronic submission language. Contractors/vendors should continue to use the existing NIH OFM email electronic invoice submission solution until the IPP transition date stated in their specific award modification. The NIH Office of Financial Management website will provide future updates on the transition to IPP. The service being procured is the transition from the NIH OFM current email electronic invoice submission solution to the Department of Treasury's IPP for electronic submission and processing of payment requests. This transition will streamline the invoice processing system for contractors/vendors working with the NIH.
    Installation of 18x Boom Arms for a Tandem Boom System (Notice of Intent to Sole Source)
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH) intends to negotiate a sole source contract for the installation of 18 new 2nd Boom Arms for a Tandem Boom system at the Clinical Center in Bethesda, Maryland. This procurement aims to replace existing respiratory boom systems in the ICU suite, which have been deemed inadequate by users, and is necessitated by delays related to COVID-19 that prevent a change order on the original purchase order. The project involves the deinstallation and reinstallation of medical gas, electrical, and telecommunication lines, along with the recertification of gas lines to ensure the functionality and safety of the new equipment. Interested parties may submit capability statements by 4:00 PM EST on September 18, 2024, to Lu Chang at lu-chang.lu@nih.gov, as this is not a request for proposal and the statutory authority for this sole source requirement is based on the unique nature of the equipment and services provided by KR Wolfe Inc. and Hillrom/Baxter.
    Notice of Intent BD Rhapsody Single-Cell Analysis Reagent Kits
    Active
    Health And Human Services, Department Of
    Notice of Intent BD Rhapsody Single-Cell Analysis Reagent Kits The Department of Health and Human Services, Department of, National Institutes of Health, is planning to procure BD Rhapsody Single-Cell Analysis Reagent Kits. These kits are used for the manufacture of human cells and tissue-based products utilized in phase I/II clinical protocols for transplantation, adoptive immunotherapy, and gene therapy conducted in the Clinical Center at the NIH. The procurement includes a standing order for multi-type sequencing kits and reagents with a short shelf life. The contractor will be responsible for shipping the sufficient reagents and kits following the scheduled delivery dates. The shelf life of the sequencing reagents should be at least 3 months, and the shelf life of library generation kits should be at least 6 months. The contractor is also required to provide technical support for all kits and reagents at no additional cost. The period of performance for this procurement is from 5/1/2024 to 8/30/2024. The delivery schedule is overnight delivery Monday through Thursday to the Center for Cellular Engineering (CCE) at NIH/CC in Bethesda, MD. The vendor will be responsible for ensuring the safe transport of cryopreserved patient cells and maintaining the temperature and other parameters during the shipment of reagents and kits. The contractor will be paid per product delivered and is required to provide hard copies of proofs of each product delivered. Interested parties can submit their capabilities to the Office of Purchasing and Contracts by May 1st, 9:00 AM EST. Please note that this is not a request for proposal.
    Notice of Intent - Ortho Clinical Reagents and Supplies
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH) intends to award a fixed-price contract for Ortho Clinical reagents and supplies, specifically for the Department of Transfusion Medicine at the NIH Clinical Center in Bethesda, Maryland. This procurement aims to secure essential analyzer supplies and reagents that are critical for ensuring the safety and effectiveness of blood products used in transfusion therapy, which must meet specific compatibility requirements for patient treatment. The selected supplier, Ortho-Clinical Diagnostics, Inc., is the sole source for these unique reagents, which have undergone extensive validation studies and are necessary for compatibility testing of both patients and blood donors. Interested parties capable of providing similar products may submit a capability statement by September 22, 2024, to Sheri Eiri at sheri.eiri@nih.gov, as the contract is contingent upon the availability of FY2025 funding.